Skip to content

Contributing Factors to Anterior Resection Syndrome and Its Impact on Quality of Life: A Retrospective Cohort Study

Contributing Factors to Anterior Resection Syndrome and Its Impact on Quality of Life: A Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04114591
Enrollment
179
Registered
2019-10-03
Start date
2018-07-01
Completion date
2019-01-30
Last updated
2019-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Low Anterior Resection Syndrome, Quality of Life

Brief summary

This study adds to the understanding of the contributing factors leading to LARS, the long term effects of this syndrome post-operatively and its impact on quality of life.

Interventions

PROCEDUREanterior resection

The distance from anal verge, preoperative radiotherapy and presence of stoma were analysed

Sponsors

University of Malta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* All adult patients \>18 years, under the care of all surgical firms at Mater Dei Hospital, who had undergone anterior resection for rectal cancer between January 2014 and December 2016

Exclusion criteria

* colorectal cancer (\>15cm) from anal verge * permanent stoma * known disseminated or recurrent disease, * patient without restitution of bowel continuity after 1 year

Design outcomes

Primary

MeasureTime frameDescription
LARS incidence1 yearIncidence of LARS in patients who had anterior resection
Risk factors1 yearVariable factors which might have contributed to LARS were the following: * Age * Gender * Diabetes mellitus * Pathological stage * MRI stage * Distance from anal verge * Surgical technique * Preoperative radiotherapy * Preoperative chemotherapy * Postoperative radio/chemotherapy * Type of anastomosis * Presence of stoma * Interval from stoma reversal * Duration of follow-up
Life1 yearThe association between LARS and quality of life was assessed.

Countries

Malta

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026